| Date | Name | Shares | Transaction | Value |
|
Dec 19, 2025
| Bryan Clark SVP of R&D and FSQ |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Dec 19, 2025
| Bryan Clark SVP of R&D and FSQ |
51,022
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.84 per share |
195,924.48
|
|
Dec 19, 2025
| Bryan Clark SVP of R&D and FSQ |
55,582
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Dec 16, 2025
| Lauren Mcnamara |
114,111
| Acquisition or disposition under a purchase/ownership plan Non-derivative transaction at $2.98 per share |
340,050.78
|
|
Dec 16, 2025
| Justin Kobler |
25,372
| Acquisition or disposition under a purchase/ownership plan Non-derivative transaction at $2.98 per share |
75,608.56
|
|
Dec 16, 2025
| Christopher Mccullough |
10,797
| Acquisition or disposition under a purchase/ownership plan Non-derivative transaction at $2.98 per share |
32,175.06
|
|
Nov 28, 2025
| Greg Gaba |
110,970
| Acquisition or disposition in the public market Non-derivative transaction at $3.39 per share |
376,188.30
|
|
Nov 28, 2025
| Greg Gaba |
100,651
| Acquisition or disposition in the public market Non-derivative transaction at $3.39 per share |
341,206.89
|
|
Oct 30, 2025
| Mahes S. Wickramasinghe |
48,311
| Compensation for services Non-derivative transaction at $5.88 per share |
284,068.68
|
|
Oct 30, 2025
| David J. Lemmon |
5,291
| Compensation for services Non-derivative transaction at $5.88 per share |
31,111.08
|
|
Oct 22, 2025
| Rebecca Fisher Director |
139,912
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $5.68 per share |
794,700.16
|
|
Oct 22, 2025
| Leslie Starr Keating Director |
138,211
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $5.68 per share |
785,038.48
|
|
Oct 22, 2025
| Diego Reynoso Director |
55,061
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $5.68 per share |
312,746.48
|
|
Oct 22, 2025
| Albert D. Bolles Director |
229,984
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $5.68 per share |
1,306,309.12
|
|
Oct 17, 2025
| Rob Duchscher |
37,525
| Exercise of rights |
0.00
|
|
Oct 17, 2025
| Rob Duchscher |
N/A
| Exercise of rights |
0.00
|
|
Jul 30, 2025
| Leslie Starr Keating Director |
39,740
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jul 29, 2025
| David J. Lemmon Director |
34,216
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jul 29, 2025
| Mahes S. Wickramasinghe Director |
35,476
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jul 29, 2025
| Richard Dean Hollis Director |
20,193
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|